Active Ingredient: POSACONAZOLE
Proprietary Name: NOXAFIL
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 300MG/16.7ML (18MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N205596
Product Number: 001
Approval Date: Mar 13, 2014
Applicant Holder Full Name: MERCK SHARP AND DOHME CORP
Marketing Status:
Prescription
Patent and Exclusivity Information
